PGXHEALTH, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8058259 R agonistsDec 18, 08Nov 15, 11[A61K, A01N]
6586183 Association of .beta.2-adrenergic receptor haplotypes with drug responseMar 16, 01Jul 01, 03[C07H, C12Q, C12P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2009/0233,942 Genetic markers associated with response to antidepressantsAbandonedMar 13, 08Sep 17, 09[A61K, C12Q]
2008/0176,858 SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORSAbandonedMar 17, 08Jul 24, 08[A61K]
2008/0166,723 CDK5 genetic markers associated with galantamine responseAbandonedJul 26, 07Jul 10, 08[C12Q]
2007/0244,134 Selective antagonists of A2A adenosine receptorsAbandonedMay 14, 07Oct 18, 07[A61K, A61P]
7250258 CDK5 genetic markers associated with galantamine responseExpiredDec 07, 04Jul 31, 07[C12Q]
2007/0049,757 Methods for the synthesis of substituted amino uracilsAbandonedAug 28, 06Mar 01, 07[C07D]
2006/0183,146 Genetic markers in the HLA-C gene associated with an adverse hematological response to drugsAbandonedFeb 10, 06Aug 17, 06[C12Q]
2006/0177,860 Genetic markers in the HLA-DQBI gene associated with an adverse hematological response to drugsAbandonedFeb 09, 06Aug 10, 06[C12Q]
2006/0178,843 Genetic markers in the CSF2RB gene associated with an adverse hematological response to drugsAbandonedFeb 09, 06Aug 10, 06[G06F]
2006/0166,219 NTRK1 genetic markers associated with progression of Alzheimer's diseaseAbandonedNov 22, 04Jul 27, 06[C12Q]
2006/0154,265 LDLR genetic markers associated with age of onset of Alzheimer's DiseaseAbandonedJan 14, 05Jul 13, 06[C12Q]
2006/0078,879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applicationsAbandonedFeb 04, 03Apr 13, 06[C07H, C12Q, C12P, C12N, C07K]
2005/0277,129 APOE genetic markers associated with age of onset of Alzheimer's diseaseAbandonedJan 14, 05Dec 15, 05[C12Q]
2005/0260,613 LRPAP1 genetic markers associated with galantamineAbandonedOct 26, 04Nov 24, 05[C12Q, C12P]
2005/0255,488 NTRK1 genetic markers associated with age of onset of Alzheimer's DiseaseAbandonedOct 13, 04Nov 17, 05[C12Q]
2005/0255,492 CHRNA9 genetic markers associated with progression of Alzheimer's diseaseAbandonedNov 22, 04Nov 17, 05[C12Q, C12P]
2005/0255,495 SLC5A7 genetic markers associated with age of onset of Alzheimer's diseaseAbandonedDec 07, 04Nov 17, 05[C12Q]
2005/0255,498 APOC1 genetic markers associated with age of onset of Alzheimer's DiseaseAbandonedJan 14, 05Nov 17, 05[C12Q]
2005/0250,118 EPHX2 Genetic markers associated with galantamineAbandonedOct 26, 04Nov 10, 05[C12Q]
2005/0250,121 NTRK2 genetic markers associated with progression of Alzheimer's diseaseAbandonedNov 22, 04Nov 10, 05[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.